Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives
Multidrug-resistant tuberculosis (MDR-TB) is on the rise, and is difficult to treat.The approval of two new drugs, bedaquiline and delamanid, and growing evidence for the use Baby Bath Oils of linezolid, offer renewed hope for addressing MDR-TB.However, access to these medicines remains a significant challenge.These drugs have not been registered f